Skip to product information
1 of 1
Regular price £100.47 GBP
Regular price £118.00 GBP Sale price £100.47 GBP
Sale Sold out
Free UK Shipping

Freshly Printed - allow 10 days lead

Fundamentals of Biologicals Regulation
Vaccines and Biotechnology Medicines

This book surveys the regulation of biologicals from an international perspective, building upon foundational information and featuring real-world case studies

Rebecca Sheets (Author)

9780128092903, Elsevier Science

Paperback, published 1 December 2017

450 pages
23.4 x 19 x 2.8 cm, 0.88 kg

Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines serves as an introduction to the international regulatory arena in which biologicals are developed and offers an overview of the processes and insight into the scientific concepts underpinning global regulations. This book will provide multiple levels of readership with guidance on basic concepts, a detailed look at regulatory challenges, and practical insight into how regulators consider regulatory science and regulatory process issues across various regions. With numerous case studies, learning activities, and real-world examples across several classes of biotechnological products, this book is a valuable and comprehensive resource for graduate students, professors, regulatory officials, and industry scientists working with biologicals.

Section I: Regulatory Process1. Introduction2. Discovery and Development of Biologicals3. International Harmonization4. Pre-IND Profess, Guidance from Regulators in Advance of a Clinical Trials Application5. Clinical Trials Approvals and Investigational New Drug Applications6. Marketing Authorization Processes7. Special Regulatory Programs8. Post-Marketing Changes to an Approved Application or Variations9. Compliance and Inspections10. Good "X" Practices

Section II: Regulatory Science11. Preclinical Safety and Toxicology12. Preclinical Proof-of-Concept and Pharmacology, Animal Use Ethics13. Genetically Modified Organisms and Institutional Biosafety Committees14. Risk Assessments15. Chemistry, Manufacturing, and Controls Information (CMC) and Process Validation16. Analytics, Analytical Validation, Lot Release, and National Control Laboratories17. Regulatory Aspects of Clinical Trials18. Ethics of Clinical Trials and the Informed Consent Process19. Institutional Review Board Processes (Ethics Committees)20. Biosimilars21. In Vitro Diagnostics22. Regulatory Policy and Public Health Policy

Subject Areas: DNA & Genome [PSAK1], Immunology [MJCM], Personal & public health [MBNH], Public health & preventive medicine [MBN], Biotechnology industries [KNDH1]

View full details